Rate My Professor Jim Polli

James E. Polli, PhD, is Professor and Ralph F. Shangraw/Noxell Endowed Chair in Industrial Pharmacy and Pharmaceutics in the Department of Pharmaceutical Sciences at the University of Maryland School of Pharmacy. He holds a PhD in Pharmaceutics from the University of Michigan and a BS in Pharmacy from the Philadelphia College of Pharmacy and Science. Polli serves as Co-Director of the University of Maryland Center of Excellence in Regulatory Science and Innovation (M-CERSI), Co-Director of the Center for Research on Complex Generics (CRCG), and Director of the online Master of Science in Regulatory Science program. He has advised 25 PhD graduates and served as an editor of Pharmaceutical Research, the flagship journal of the American Association of Pharmaceutical Scientists, for 12 years. His career includes significant contributions to pharmaceutical education and research leadership at the University of Maryland, Baltimore.

Polli's research specializations encompass oral drug absorption, maximizing oral bioavailability through formulation and chemical approaches, and developing public quality standards for oral dosage forms. Key publications include 'Understanding pharmaceutical quality by design' (Yu et al., The AAPS Journal, 2014), 'Biopharmaceutics classification system: the scientific basis for biowaiver extensions' (Yu et al., Pharmaceutical Research, 2002), 'Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets' (Polli et al., Journal of Pharmaceutical Sciences, 1997), 'In Vitro Studies Are Sometimes Better than Conventional Human Pharmacokinetic In Vivo Studies in Assessing Bioequivalence of Immediate-release Solid Oral Dosage Forms' (Polli, The AAPS Journal, 2008), and 'Efficiency of single pharmaceutical surfactants to mimic intestinal biorelevant media solubilization and dissolution of etravirine: Comparison of intrinsic and film dissolution models' (Oktay and Polli, European Journal of Pharmaceutics and Biopharmaceutics, 2024). He is a Fellow of the American Association of Pharmaceutical Scientists and has received the American Pharmacists Association Takeru Higuchi Research Prize as its 14th recipient, the 2024 American Association of Colleges of Pharmacy Volwiler Research Achievement Award, the 2022 AAPS Global Leadership Award, and the 2021 TOPRA Education Award. Polli was recognized as an MPower Professor for his contributions to research and education.